Literature DB >> 27855389

Expression of MicroRNA-301a and its Functional Roles in Malignant Melanoma.

Lei Cui1, Yuejun Li, Xiaoxing Lv, Jinqing Li, Xiaolin Wang, Zhanjun Lei, Xueyong Li.   

Abstract

BACKGROUND/AIMS: Although microRNA-301a has been reported to function as an oncogene in many human cancers, the roles of miR-301a in malignant melanoma (MM) is unclear. The present study aims to investigate the functional roles of miR-301a in MM and its possible molecular mechanisms.
METHODS: Quantitative real-time PCR (qRT-PCR) assay was performed to detect the expression of miR-301a in MM tissues, and analyze its correlation with metastasis and prognosis of MM patients. In vitro, miR-301a was ectopically expressed using overexpression and knock-down strategies, and the effects of miR-301a expression on growth, apoptosis, migration, invasion and chemosensitivity of MM cells were further investigated. Furthermore, the potential and functional target gene was identified by luciferase reporter, qRT-PCR, Western blot assays.
RESULTS: We showed that the expression of miR-301a was significantly upregulated in MM tissues, and upregulation of miR-301a correlated with metastasis and poor prognosis of MM patients. Transfection of miR-301a/inhibitor significantly inhibited growth, colony formation, migration, invasion and enhanced apoptosis and chemosensitivity in MM cells, while transfection of miR-301a/mimic could induce the inverse effects on phenotypes of MM cells. Luciferase reporter, qRT-PCR and Western blot assays showed that phosphatase and tensin homolog (PTEN) was a direct and functional target of miR-301a. It was also observed that the Akt and FAK signaling pathways were involved in miR-301/PTEN-promoting MM progression.
CONCLUSION: Taken together, our study suggests that miR-301a may be used as a potential therapeutic target in the treatment of human MM.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27855389     DOI: 10.1159/000452540

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  17 in total

1.  Systematic Review and Meta-analysis of the Prognostic Significance of miRNAs in Melanoma Patients.

Authors:  Shanthi Sabarimurugan; Madhav Madurantakam Royam; Ankita Das; Shrestha Das; Gothandam K M; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2018-12       Impact factor: 4.074

Review 2.  MicroRNA Signature in Melanoma: Biomarkers and Therapeutic Targets.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

Review 3.  New Treatment Opportunities in Phosphatase and Tensin Homolog (PTEN)-Deficient Tumors: Focus on PTEN/Focal Adhesion Kinase Pathway.

Authors:  Roberta Alfieri; Elisa Giovannetti; Mara Bonelli; Andrea Cavazzoni
Journal:  Front Oncol       Date:  2017-08-09       Impact factor: 6.244

4.  Development and validation of a plasma-based melanoma biomarker suitable for clinical use.

Authors:  Ryan Van Laar; Mitchel Lincoln; Barton Van Laar
Journal:  Br J Cancer       Date:  2018-01-23       Impact factor: 7.640

5.  MiR-301a Promotes Cell Proliferation by Repressing PTEN in Renal Cell Carcinoma.

Authors:  Jun Li; Donggen Jiang; Qian Zhang; Shubin Peng; Guolong Liao; Xiangwei Yang; Jiani Tang; Haiyun Xiong; Jun Pang
Journal:  Cancer Manag Res       Date:  2020-06-10       Impact factor: 3.989

Review 6.  Regulation of PTEN expression by noncoding RNAs.

Authors:  Wang Li; Ting Zhang; Lianying Guo; Lin Huang
Journal:  J Exp Clin Cancer Res       Date:  2018-09-10

7.  MicroRNA (MiR)-301a-3p regulates the proliferation of esophageal squamous cells via targeting PTEN.

Authors:  Nan Zhang; Jun Feng Liu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

8.  Elevated miR-301a expression indicates a poor prognosis for breast cancer patients.

Authors:  Jin-Zhou Zheng; Yan-Ni Huang; Ling Yao; Yi-Rong Liu; Sheng Liu; Xin Hu; Zhe-Bin Liu; Zhi-Min Shao
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

9.  MicroRNA miR-301a is a novel cardiac regulator of Cofilin-2.

Authors:  Ashraf Yusuf Rangrez; Phillip Hoppe; Christian Kuhn; Elisa Zille; Johanne Frank; Norbert Frey; Derk Frank
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

Review 10.  Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development.

Authors:  Rayan Naser; Abdullah Aldehaiman; Escarlet Díaz-Galicia; Stefan T Arold
Journal:  Cancers (Basel)       Date:  2018-06-11       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.